Accord Healthcare, Inc. recalls
14 recalls filed under Accord Healthcare, Inc.. The most recent was published September 2, 2026.
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 112 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 88 mcg , 1000-count bottles recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 100 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 175 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 150 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 75 mcg , 1000-count bottles recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 300 mcg , 90-count bottles recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 137 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 25 mcg , 1000-count bottles recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 125 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 50 mcg , 1000-count bottles recall: Subpotent Drug
Subpotent Drug
-
Class II · last month
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 200 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 4 months ago
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 300 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 1+ years ago
Accord Healthcare, Inc. Levothyroxine Sodium Tablets, USP, 88 mcg recall: Subpotent: During long term stability testing of Levothyroxine Sodium Tablets
Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved…
About this page
Accord Healthcare, Inc. appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.